Figure 2.
EFS following tyrosine kinase inhibitor treatment discontinuation. The 5-year EFS was 67% and the median duration of CMR was 20 months. EFS, event-free survival; CMR, complete molecular response.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.